Related Experiment Videos
Macrophage killing of human papillomavirus type 16-transformed cells
M Denis1, K Chadee, G J Matlashewski
1Institute of Parsitology, McGill University, Macdonald College, Ste-Anne de Bellevue, Québec, Canada.
Abstract:
Papillomaviruses (HPV) are involved in proliferation of epithelial cells and are implicated in several human malignancies. We determined the capability of activated macrophages to exert cytostatic and/or cytolytic activities against HPV type 16 DNA-transformed cells. Both NIH-3T3 and A31-3T3 cells transformed with HPV DNA were susceptible to killing by activated macrophages; however, transformed and nontransformed cells were not susceptible to killing by soluble mediators. The HPV-transformed cells were as resistant as their nontransformed counterparts to recombinant TNF-alpha. These data suggest that the killing of the HPV-16-transformed 3T3 cells by macrophages occurred by a mechanism independent of TNF-alpha.
Insights
Activated macrophages can kill human papillomavirus (HPV) type 16 DNA-transformed cells. This killing mechanism is independent of tumor necrosis factor-alpha (TNF-alpha), suggesting a novel therapeutic target for HPV-related cancers.
Area of Science:
- Immunology
- Oncology
- Virology
Background:
- Human papillomaviruses (HPV) are linked to epithelial cell proliferation and human cancers.
- Understanding immune responses to HPV-infected cells is crucial for developing cancer therapies.
Purpose of the Study:
- To investigate the ability of activated macrophages to eliminate cells transformed by HPV type 16 DNA.
- To determine if the killing mechanism involves soluble mediators like TNF-alpha.
Main Methods:
- Co-culture of activated macrophages with NIH-3T3 and A31-3T3 cells transformed with HPV DNA.
- Assessment of cell susceptibility to macrophage-mediated killing and soluble mediators, including recombinant TNF-alpha.
Main Results:
- Both HPV-transformed and nontransformed NIH-3T3 and A31-3T3 cells were susceptible to killing by activated macrophages.
- Transformed and nontransformed cells showed similar resistance to soluble mediators.
- HPV-16-transformed cells exhibited resistance to recombinant TNF-alpha, comparable to nontransformed cells.
Conclusions:
- Activated macrophages possess the capability to exert cytostatic and/or cytolytic effects on HPV-16-transformed cells.
- The killing mechanism employed by macrophages against these transformed cells is independent of TNF-alpha.
- These findings suggest potential immunotherapeutic strategies targeting HPV-related malignancies.